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INTRODUCTION AND HISTORICAL BACKGROUND 
The genus Citrobacter was proposed by Werkman and Gil-
len (1932) to include those Gram-negative enteric bacilli 
that were not typically Escherichia coli or Aerobacter 
aerogenes. Because of the ability of those "coli-aerogene 
intermediates" to utilize citrate as a sole source of carbon 
and to produce trimethylene glycol, these authors suggested 
the name Citrobacter for the group, and placed the 15 iso-
lates they studied in seven species: ~· freundii (type 
species), C. album,~· anindolicum, ~· decolorans, C. 
diversum, C. glycologenes, and ~· intermedium. 
This suggestion by Werkman and Gillen was not accepted 
by a number of investigators including Yale (1939) and 
Vaughn and Levine (1942) who transferred C. freundii and 
C. intermedium, respectively, to the genus Escherichia. 
A closely related group, the Bethesda-Ballerup group, 
was found by West and Edwards (1954) to resemble, biochem-
cially and serologi~ally, ~· freundii. Based chiefly on 
this study, the International Enterobacteriaceae Subcommittee 
1 
recognized in 1958 the genus Citrobacter and accepted the 
l designation of ~· freundii (Braak) as its type species. A complete discussion of the history of this genus and re-
lated organisms appears in Edwards and Ewing (1972). Ac-
cording to these authors, Citrobacter is a member of the 




"The genus Citrobacter is composed of motile bac-
teria that conform to the definitions of the fam-
ily Ent~robac .teriaceae and the tribe Salmonellae. 
Lysine is not decarboxylated and less than 20% of 
strains possess ornithine decarboxylase. Urease 
is produced by a majority of cultures, but the 
reactions are weak. Growth occurs in medium that 
contains potassium cyanide and acid is produced 
in Jordan's tartrate medium. Dulcitol and cell-
obiose are fermented rapidly by the majority of 
the cultures. Lactose is utilized but the reac-
tions are frequently delayed. The type species 
is Citrobacter freundii (Braak) Werkman and Gil-
len." (p. 276) 
Today, three species are recognized in the genus: C. 
freundii, £. amalonaticus, and C. diversus. C. freundii 
is known to occur as three varieties: £. freundii H
2
s +, 
IND - C. freundii H
2





It should be noted at this point that a suggestion was 
made (Young et al, 1974) to transfer C. diversus to the new-
ly-created genus, Levinea. Although this suggestion h~s not 
been accepted officially, some authors refer to the organism 
as C. diversus-Levinea. However, for the purpose of this 
study, it will be referred to as £. diversus. 
The role of Citrobacter in disease has not been invest-
igated thoroughly. The organism is a normal inhabitant of 
the human intestine, being as common as Escherichia coli in 
infants. With age, the child's intestine begins to show a 
greater ratio of E. coli to Citrobacter (Nahhas, personal 
communication). Citrobacter has been reported as a cause 
of urinary and respiratory tract infections, especially in 
3 
children. Hodges et al (1978), however, believe that in 
most cases, Citrobacter is found in a commensalistic rela-
tionship with the organism(s) . causing the infection. Most 
patients from whom Citrobacter was cultured had underlying 
diseases or factors predisposing them to infection. Out-
breaks of neonatal meningitis in hospital maternity wards 
and nurseries have been attributed to contamination of 
nurses' hands and equipment by f. diversus (Anderson et al, 
1981; Enzenauer et al, 1982). Osteomyelitis, neonatal dia-
rrhea, neonatal septicemia, and brain abscesses caused by 
Citrobacter have also been reported (Barton and Walentik, 
1982). 
In January 1983, I began a study of this group with two 
objectives in mind: to study the biochemical and antibio-
gram characteristics of Citrobacter isolates from Stockton, 
California, and, if possible, to expand and update informa-




MATERIALS AND METHODS 
Bacterial Strains 
A total of 109 strains of Citrobacter spp. were obtain-
ed between January 5, 1983 and February 29, 1984. These 
isolates were taken from clinical material recovered by the 
Microbiology Department at Dameron Hospital, Stockton, Cali-
fornia. The specimens were one bronchial washing, one gall 
bladder, 97 stools, one umbilical cord, seven urine samples, 
and two wound. These were recovered from blood agar and/or 
EMB plates, and in the case of stools, Yersinia Selective 
Medium (YSM; Hana Co., Berkeley, CA). Most of the stool 
isolates were identified presumptively by their colonial 
morphology on YSM (red-colored colony) and reactions on 
Simmons' citrate (positive) and urea agar slants (negative 
or slightly positive). Single colonies were subcultured on 
tryptic soy agar slants and stored at 2-8°C for further 
biochemical and antibiogram studies. 
Biochemical Studies 
Identification of the isolates was based on the bio-
chemical test results of the API 20E strip, a commercial 
kit purchased from Analytab Products, Inc., New York. These 
tests consist of beta-galactosidase (ONPG), arginine dihy-
drolase (ADH), lysine decarboxylase (LDC), ornithine decar-
boxylase (ODC), sodium citrate (CIT), hydrogen sulfide (H2S), 





Vogues-Proskauer (VP), gelatin liquefaction (GEL), and nine 
carbohydrate fermentation tests: glucose (GLU), mannitol 
(MAN), inositol, (INO), sorbitol (SOR), rhamnose (RHA), 
sucrose (SAC), melibiose (MEL), amygdalin (AMY), and arabin-
ose (ARA). Each strip was inoculated according to manufac-
turer's instructions. A small amount of each isolate was 
added to a test tube containing five ml of a 0.85% sterile 
saline solution (pH 5.5-7.0). Using a sterile pipette, the 
API 20E strip tubes were inoculated with the saline suspen-
sian. Tubes containing citrate, Vogues-Proskauer, and gela-
tin were filled to the rim with additional inoculum; sterile 
mineral oil was added to the tubes containing arginine dihy-
drolase, lysine decarboxylase, ornithine decarboxylase, 
hydrogen sulfide, and urease to provide anaerobic conditions. 
0 
Each API strip was incubated for 18-24 hours at 35 C. Fol-
lowing incubation, positive results were noted and recorded. 
Positive results for the various tests are indicated in par-
entheses as follows: ONPG (yellow); ADH, LDC, ODC, URE (red 
or orange); CIT (turquoise or dark blue); H2S (black depos-
it); TDA (brown after adding one drop of 10% Fecl
3
); · IND 
(red ring after adding one drop Kovac's reagent); VP (red 
after adding one drop of 40% KOH and one drop of alpha-naph-
thol); GEL (diffusion of black pigment); GLU, MAN, INO, SOR, 
RHA, SAC, MEL, AMY, ARA (yellow). The strips were reincu-
bated for another 18-24 hours to note any delayed reactions. 




of results obtained from each strain. The oxidase (OXI) 
test made up the twenty-first test for this purpose. The 21 























Negative results were assigned a value of zero. Positive 
reactions were assigned a numerical value of one, two, or 
four, depending upon the location of the test within a 
group. A value of one was assigned for the first biochemi~ 
cal test in each group (ONPG, ODC, URE, VP, MAN, RHA, AMY). 
A value of two corresponds to the second biochemical test in 
each group (ADH, CIT, TDA, GEL, INO, SAC, ARA) and a value 
of four was assigned to the third test in each group (LDC, 
H2S, IND, GLU, SOR, MEL, OXI). A seven-digit profile number 
is obtained by adding the values within a group. An example 
follows for the results corresponding to the number 1204573: 
ONPG ADH LDC ODC CIT H2S URE TDA IND 
+ + 
l~l/0 0~!/ o~l/o ·o 
7 
VP GEL GLU MAN INO SOR RHA SAC MEL 
+ + + + + + 
1 0 4 
~1/ 
AMY ARA OXI 
+ + 
A differential chart located in the API Profile for Entero-
bacteriaceae allows species identification on the basis of 
profile number. For example, profile number 1204573 keys 
out to f. freundii H2 s -, IND -
In addition to the API ZOE, citrate utilization was 
also studied in two other media: Simmons' citrate agar 
slants (Difco; sodium citrate 0.2%, magnesium sulfate 0.02%, 
ammonium dihydrogen phosphate 0.1%, dipotassium phosphate 
0.1%, sodium chloride 0.5%, agar 1.5%, brom-thymol blue 
0.008%) and Koser's citrate broth (Difco; sodium citrate 
0.3%, sodium ammonium phosphate 0.15%, monobasic potassium 
phosphate 0.1%, magnesium sulfate 0.02%). 
Antibiotic Susceptibility Testing 
Antibiotic susceptibility testing was conducted using 
the Kirby-Bauer standardized disc method (Bauer et al, 1966). 
Tryptic soy agar, however, was used instead of Mueller-Hin-
ton medium. The plates were prepared by dissolving 40 gm of 
dehydrated medium in one liter of deionized water and dis-
1 
8 
pensing 66 ml into large screw-cap test tubes. After auto-
claving, the tubes were allowed to cool and harden for star-
age. When needed, tubes were reautoclaved for five minutes 
and the media poured into sterile 150 mm plastic Petri 
dishes. 
follows: 
Susceptibility testing procedures were conducted as 
A small inoculum from a slant was introduced into 
a tryptic soy broth and incubated. The turbidity of ac-
tively growing cultures was then adjusted so as to obtain a 
suspension comparable to that of a barium chloride standard 











(1%, vol/vol). This 
is half the density of a McFarland No. 1 standard. Using a 
sterile cotton swab, a small amount of the suspension was 
streaked on the plates to insure even distribution of bac-
teria. The surface was allowed to dry for five to fifteen 
minutes and then antibiotic discs were placed on the surface 
of the plate using a 12-magazine-150 mm dispenser (Difco). 
The plates were incubated at 35°C for 18-24 hours and the 
diameter of each zone of inhibition was measured to the 
nearest mm. These diameters were compared to the standard 
chart (~able III) for interpretation of results. 
All data was entered into the University of the Pacific 
(Stockton, CA) Burrough's B6700 large-systems computer by 
interactive terminal. The Statistical Package for the So-
cial Sciences (SPSS) subroutine CROSSTABS was used to per-




The computer-based profile system developed by Analytab 
Products for the API 20E places the 109 isolates into three 
species: C. freundii, 89 isolates (81.65%); f. diversus, 
11 isolates (10.09%); and C. amalonaticus, nine isolates 
(8.26%)(Table I). 
The majority, or 64 (71.91 %) of the 89 f. freundii iso-
lates were H2s +, indole-, 17 (19.10%) were H2 S -, indole 
and eight (8.99%) were H
2
s +, indole +. The distribution 
of the H
2
s +, IND - strains indicates a predominance (58 
isolates or 90.63%) in stools, five (7.81%) in urine, and 
one (1.56%) from a wound culture. Fifteen of the 17 isolates 
of H2s -, indole -f. freundii (88.24%) were also of intest-
inal origin, one (5.88%) from the gall bladder, and one 
(5.88%) from a wound. Seven of the eight H
2
s +, indole + 
f. freundii (87.50%) were stool isolates and one (12.50%) 
from a bronchial wash. 
Of the 11 C. diversus isolatei, eight (72.72%) were 
from stools, two (18.18%) from urine, and one (9.09%) from 
the umbilical cord stub of a newborn infant. 
All nine isolates of C. amalonaticus were recovered 





~2 s +, Indole - Biotype 
Biochemical Activities 
The biochemical activities of H
2
S +, indole - C. 
freundii obtained in this study are shown in Table II. All 
64 isolates were oxidase negative, failed to decarboxylate 
lysine, deaminate tryptophan, and produce urease and indole. 
The Vogues-Proskauer and gelatin liquefaction tests were also 
negative. All strains utilized Koser's citrate, produced 
H
2
S after 48 hours (98% at 24 hours), and fermented glucose, 
lactose (ONPG), mannitol, rhamnose, and arabinose. Ninety-
five percent of the isolates utilized Simmons' citrate and 
fermented sorbitol. Over 70% produced arginine dihydrolase 
after 48 hours (25% at 24 hours) and fermented sucrose and 
melibiose. Less than 40% decarboxylated ornithine, utilized 
citrate on the API strip, and fermented amygdalin. Inositol 
was fermented by only 9% of the isolates. 
Antibiotic Susceptibility 
The antibiogram for H2 s +, indole - C. freundii is 
shown in Table IV. All isolates were sensitive to cefaman-
dole, cefotaxime, cefoperazone, gentamicin, amikacin, tobra-
mycin, polymyxin B, naladixic acid, mezlocillin, and pipera-
cillin. Over 90% were sensitive to carbenicillin, moxalac-
tam, tetracycline, kanamycin, chloramphenicol, nitrofuran-
toin, and neomycin. Ninety-seven percent were resistant to 
10 
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cephalothin while 95% were resistant to cefoxitin. Over 80% 




~2 s +, indole + Biotype 
Biochemical Activities 
The biochemical activities of the H2 s +, indole + ~· 
freundii biotype are shown in Table II. All eight strains 
were oxidase, lysine decarboxylase, and tryptophan deaminase 
negative; negative reactions were also seen in urease, 
Vogues - Proskauer, and gelatin liquefaction tests. All eight 
isolates failed to ferment inositol. All isolates produced 
ornithine decarboxylase and utilized citrate on the API 
strip, Simmons' slant, and Koser's citrate broth; all 
strains produced H2 s and indole, and fermented glucose, lac-
tose (ONPG), mannitol, sorbitol, rhamnose, sucrose, and ara-
binose. Seventy-five percent produced arginine dihydrolase 
after 48 hours (0% at 24 hours) and 88% fermented melibiose 
and amygdalin. 
Antibiotic Susceptibility 
The antibiotic susceptibility pattern of H2 s +, indole 
+ C. freundii is shown in Table IV. All strains were resis-
tant to cephalothin and cefoxitin, but sensitive to carbeni-
cillin, cefamandole, cefotaxime, cefoperazone, moxalactam, 
tetracycline, gentamicin, kanamycin, amikacin, tobramycin, 
polymyxin B, chloramphenicol, gantrisin, trimethoprim-sulfa-
methoxazole (Bactrim-Septra), nitrofurantoin, naladixic 
acid, neomycin, mezlocillin, 'and piperacillin. 





The biochemical activities of the H
2
s -, indole - f. 
freundii biotype are shown in Table II. All 17 isolates 
were oxidase, lysine decarboxylase, and tryptophan deaminase 
negative, and failed to produce H
2
s, urease, and indole. 
Negative reactions were also seen in the Vogues-Proskauer 
and gelatin liquefaction tests. All isolates utilized 
Koser's citrate and fermented glucose, lactose (ONPG), man-
nitol, sorbitol, rhamnose, and arabinose. Inositol was not 
fermented. Over 90% of strains utilized Simmons' citrate 
and fermented sucro~e, and 71% produced arginine dihydrolase 
after 48 hours (6% at 24 hours). Eighty-two percent ferment-
ed melibiose in 48 hours (76% at 24 hours). Less than 36% 
decarboxylated ornithine and utilized citrate on the API 
strip; amygdalin was fermented by only 24%~ 
Antibiotic Susceptibility 
The antibiotic susceptibility pattern for H2 s -, indole 
- C. freundii is shown in Table IV. All isolates were re-
sistant to cefoxitin, but sensitive to ampicillin, carbeni-
cillin, cefamandole, cefotaxime, cefoperazone, moxalactam, 
tetracycline, gentamicin, kanamycin, amikacin, tobramycin, 
polymyxin B, chloramphenicol, gantrisin, trimethoprim-sulfa-
methoxazole (Bactrim-Septra), nitrofurantoin, naladixic 
acid, neomycin, mezlocillin, and piperacillin. Ninety-four 
13 
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The biochemical activities of C. diversus strains ob-
tained in this study are shown in Table II. All 11 strains 
of C. diversus were oxidase negative, failed to decarboxyl-
ate lysine, produce H2 S, urease, and tryptophan deaminase, 
and gave negative reactions in the Vogues-Proskauer and gel -
atin liquefaction tests. All isolates produced arginine di-
hydrolase at 48 hours (91% at 24 hours), decarboxylated or-
nithine, utilized citrate on the API strip, produced indole, 
and fermented glucose, lactose (ONPG), mannitol, sorbitol, 
rhamnose, and arabinose after 48 hours (91% at 24 hours). 
Ninety-one percent of the isolates fermented sucrose, 88% 
amygdalin, and 64% inositol (55% at 24 hours); only 36% of 
the strains fermented melibios e . 
Antibiotic Susceptibility 
The antibiotic pattern of C. diversus is shown in Table 
IV. All isolates showed a resistance to ampicillin and car-
benicillin, but a sensitivity to cephalothin, cefamandole, 
cefoxitin, cefotaxime, cefoperazone, moxalactam, tetracy-
cline, gentamicin, kanamycin, amikacin, tobramycin, polymyx-
in B, chloramphenicol, gantrisin, trimethoprim-sulfamethoxa-
zole (Bactrim-Septra), nitrofurantoin, naladixic acid, neo-




The biochemical activities of c. amalonaticus strains 
obtained in this study are shown in Table II. All nine C. 
amalonaticus isolates were o x idase negative, failed to de-
carboxylate lysine, produce H
2
s, urease, and deaminate tryp-
tophan ; the Vogues-Proskauer and gelatin liquefaction tests 
were also negative. All strains decarboxylated ornithine, 
produced indole, and fermented glucose, lactose (ONPG), man-
nitol, sorbitol after 48 hours (78 % at 24 hours), rhamnose, 
and arabinose; Simmons' citrate and Koser's citrate also 
gave positive reactions. Over 70% of isolates utilized ci-
trate on the API strip and fermented sucrose and amygdalin. 
Only one isolate (11%) produced arginine dihydrolase after 
48 hours and no isolates showed inositol fermentation. 
Antibiotic Susceptibility 
The antibiotic susceptibility pattern for ~· amalonati-
cus is shown in Table IV. All isolates were sensitive to 
ampicillin, cephalothin, cefamandole, cefoxitin, cefotaxime, 
cefoperazone, moxalactam, tetracycline, gentamicin, kanamy-
cin, amikacin, tobramycin, polymyxin B, chloramphenicol, 
gantrisin, trimethoprim-sulfamethoxazole (Bactrim-Septra), 
nitrofurantoin, naladixic acid, neomycin, mezlocillin, and 
piperacillin. Eighty-nine percent of the isolates showed 
sensitivity to carbenicillin. 
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DISCUSSION 
The largest . number (97) of Citrobac~er isolates were 
recovered from stools. The Yersirtia Selective Medium (YSM) 
was introduced in the mid-1970's for recovery of the enter-
ic pathogen, Yersinia enterocolitica. YSM is not inhibi-
tory to Citrobacter. The recovery of these species, there-
fore, was not unexpected since the intestine is one of the 
normal habitats for members of this genus. Citrobacter 
species can also be isolated from soil, water, food, and 
the gastrointestinal tracts of vertebrates other than hu-
mans. 
Initially thought to be commensals or saprophytes, 
they have now been causally associated with opportunistic 
infections in children and adults (Barton and Walentik, 
1982). These organisms have recently been isolated from 
bone, synovial fluid, peritoneal fluid, perinephric abscess, 
skin ulcers, ear, and vaginal discharges (Hodges et al, 
1978). According to these researchers, extraintestinal in-
fections by Citrobacter are seen mostly in those patients 
who are elderly, debilitated, and/or immunocompromised. 
The 97 fecal isolates encountered in this study were 
from cultures submitted for "enteric pathogens." 
ic pathogens were recovered from these cultures. 
No enter-
The 97 
isolates were present with several other species and con-
stitute a part of the normal intestinal flora. There is no 
17 
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reason to attribute a pathogenic role to them in the intest-
inal tract. 
The 12 isolates that were recovered from extrafecal 
sources included seven from urine, two from wounds, one from 
the umbilical cord of a newborn, one from a gall bladder, 
and one from a bronchial washing. 
All seven urine isolates, five C. freundii and two C. 
diversus, were found in numbers exceeding 10 5 /ml per culture, 
which definitely suggests urinary tract infections. The two 
wound cultures and the bronchial washing showed mixed infec-
tions, with C. freundii occurring in small numbers. Here, 
C. freundii may be assumed to be a contaminant. The isolate 
from the umbilical cord, a strain of C. diversus, was found 
in large numbers. Whether this finding represents a coloni-
zation of that site, or an actual infection was not deter-
mined. The gall b1adder isolate, f. freundii, was found as 
a mixed culture with Klebsiella pneumoniae, both occurring 
in large numbers. Since the gall bladder is normally a 
sterile area, the presence of the two organisms represents 
a true infection. It may be concluded that the present 
study suggests at least a definite pathogenic role for 
Citrobacter freundii and C. diversus in urinary tract and 
gall bladder infections. 
A large number of biochemical tests were performed in 
this study to ascertain proper identification. Tables V, 
VI, and VII compare the results of these tests with those of 
1 
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Ewing and Davis (1971, 1972) and Edwards and Ewing (1972). 
These authors did not, however, distinguish among the three 
biochemical types of C. freundii. 
It should be noted that certain tests on the API ZOE 
strip do not correlate well with tests in the conventional 
media used in the above studies (for example, citrate and 
urease); however, when the citrate test was performed using 
conventional media, the results were similar to those of 
previous studies. Aldredge et al (1978) performed a study 
that compared the API ZOE and Micro-ID (General Diagnostics, 
Morris Plains, NJ), another rapid multi-test biochemical 
identification kit, with conventional media. He found that 
discrepancies could occur between either the API ZOE or 
Micro-ID kits and conventional media. It was found that, in 
a sample of 144 Citrobacter isolates, the Micro-ID misident-
ified four isolates and the API ZOE, nine; only one was mis-
identified by conventional media. The authors hypothesized 
that the discrepancy in test results may be due to differing 
concentrations of reactants (in the citrate test, Koser's 
citrate uses 0.3% sodium citrate, Simmons' citrate contains 
O.Z% sodium citrate, and API ZOE contains 0.8% sodium ci- ; 
trate) or that sensitivities of the substrate/reagent/inert 
compounds concentrations caused certain tests to have a ten-
dency to emphasize either a positive or a negative reaction. 
It is possible, for example, that further incubation of the 
API ZOE, for 7Z or 96 hours, may produce a higher percentage 
20 
of positive reactions for citrate. 
Identification of a species does not depend on any sin-
gle test but rather a battery of tests. Computer-based 
identification schemes, such as the API ZOE kit, take this 
fact into consideration and permit proper identification 
based on several profile numbers for each species. 
When Edwards and Ewing carried out their studies on 
Citrobacter freundii, they apparently ignored any signifi-
cance of H
2
S and indole reactions, and worked on the assump-
tion that there were no subspecies of C. freundii. However, 
today we know that there are at least three biochemical 
types (subspecies) of C. freundii based on their ability to 
produce H
2
S and indole (or lack thereof). 
Table II indicates th~t there is only one major differ-
ence between C. diversus and ~· amalonaticus; arginine di-
hydrolase is produced by the former but not the latter. In 
the present study, inositol was fermented by 64% (55% at 24 
hours) of ~· diversus, but not by any of the strains of C. 
amalonaticus. The studies of Ewing and Davis (Table VI) and 
those of Edwards and Ewing (Table VII), however, show nega-
tive reactions for inositol by their strains of ~· diversus 
and~· amalonaticus (in~· amalonaticus, 1.6% fermented ino-
sitol). This discrepancy again may be accounted for by the 
use of a commercial kit in the present study instead of con-
ventional media. The point to be emphasized is that there 
is one test (out of 20) that distinguishes ~ · diversus from 
21 
C. amalonaticus. 
The battery of tests used by Werkman and Gillen (1932) 
was relatively e~tensive and consisted of 37 substrates, 
including ammonium chloride, catalase, citrate, gelatinase, 
hydrogen sulfide, indole, litmus milk, methyl red, nitrate 
reduction, urease, Vogues-Proskauer, and carbohydrates: 
aesculin, amygdalin, arabinose, dextrin, dulcitol, erythri-
tol, glucose, galactose, glycerol, glycogen, inositol, inu-
lin, lactose, levulose, maltose, mannitol, mannose, melezi-
tose, raffinose, rhamnose, salicin, sorbitol, starch, su-
erose, trehalose, and xylose. Fourteen of these 37 tests 
are represented on the API 20E strip. Table X lists and 
compares the reactions of the seven "species" of Werkman and 
Gillen with the Dameron Hospital isolates. 
We should remember, however, that the description of 
the seven "species" was based on a total of 15 cultures (the 
number of each culture tested appears in parentheses ne x t to 
the "species" in Table X). C. diversum of Werkman and Gil-
len differs from~· diversus by its ability to produce H2s. 
c. amalonaticus does not match any of the Werkman and Gil-
len species. The only H2 S negative "species" is C. glycolo-
genes, but this strain is also indole negative. Werkman and 
Gillen (1932) considered C. interm~dium (deposited by Werk-
man and Gillen as ATCC 6750 in the American Type Culture 
Collection, Rockville, MD) as a non-H 2S-producer. 
The ori-
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ginal description "appears to be in error" according to the 
twelfth edition (1976) of Catalogue of Strains I of the 
American Type Culture Collection, page 42. The only con-
elusion that can be made is that all of the "species" of 
Werkman and Gillen, except for the two isolates of C. de-
colorans, are probably Citrobacter freundii. Only two 
strains of the "species" described by Werkman and Gillen are 
available for study (ATCC strains 6750 and 8090) and both 
are recognized today as Citrobacter freundii (H 2 s +, indole 
-biochemical type). 
Based on the biochemical results of this study, the 
generic definition of Citrobacter may be emended as follows: 
The genus Citrobacter is composed of motile bac-
teria that conform to the definitions of the 
family Enterobacteriaceae. Lysine decarboxylase 
is not produced; ornithine decarboxylase and ar-
ginine dihydrolase production are variable. 
Urease is produced by a majority of cultures, but 
the reactions are weak. Growth occurs in medium 
that contains potassium cyanide and acid is pro-
duced in Jordan's tartrate medium. Dulcitol, 
cellobiose, mannitol, rhamnose, and arabinose are 
fermented. Lactose is utilized but the reactions 
frequently are delayed; however, orthonitrophenol-
beta-D-galactosidase (ONPG) is positive. Oxidase, 
Vogues-Proskauer, and gelatinase tests are nega-
tive. The type species is Citrobacter freund~i 
(Braak) Werkman and Gillen. 
The use of antibiograms as an aid in the identification 
of bacteria is not new. It has been used to identify cer-
tain anaerobes, especially members of B~~teroides, Pepto-
streptococcus, Pept6coccus, and Ftisab~cte~ium. It has also 
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been applied to Pseudomonas, and recently, the Klebsiella-
Enter6bacter-Ser~atia group (Hall, 1976). The basis for the 
use of an antibiogram in the identification of a bacterial 
agent is that certain genera or species are innately resis-
tant to certain antibiotics; for example, all members of the 
genus Proteus are resistant to polymyxin B. Klebsiella 
pneumoniae and K. oxytoca are resistant to carbenicillin but 
sensitive to cephalothin, in contrast with members of the 
genera Serratia and Enterobacter, which are sensitive to the 
former but resistant to the latter (Darland, 1975; Nahhas, 
personal communication). 
It is a common practice among bacteriologists to accept 
a trait as a major characteristic of a genus or a species if 
90% or more of the strains exhibit this trait. This assump-
tion, which works well for biochemical activities, may be 
applied, in a modified manner, to antibiotic patterns pro-
vided that antibiotic susceptibility studies are conducted 
under the same standardized conditions. 
It should be pointed out that r~sistance of an organism 
to an antibiotic may be an innate characteristic of a genus 
as indicated above. Susceptibility, however, may change 
over a period of time as a result of mutations or plasmid-
mediated transfer. 
Using 90% as a guideline, one may make the conclusion 
that, as far as Citrobacter is concerned, its three species 
may be distinguished (chi square, ~=0.05, Table IV) by a 
24 
pattern that involves the antibiotics ampicillin, carbeni-
cillin, cephalothin, and cefoxitin. The other antibiotics 
showed uniform activity on all species. Because of possible 
differ~nces in culture techniques and media batches, the 
interpretation of the data was somewhat flexible. Table III 
indicates that a difference of one mm in the size of the 
zone of inhibition may make a difference between an organism 
being "fully susceptible" to an antibiotic or "intermediate" 
in susceptibility, or between intermediate susceptibility 
and resistance. Table IV shows only susceptibility and re-
sistance; all isolates that showed a zone size indicating 
intermediate susceptibility were placed either in the "sus-
ceptible" group or the "resistant" group depending on how 
close the zone size was to the lower limit of susceptibility 
or the upper limit of resistanc~. This is a standard pro-
cedure accepted by clinical microbiologists and is based on 
the observations that differing lots of media, antibiotic 
susceptibility discs, and concentration of inoculum affect, 
to a certain degree, the size of the zone of inhibition. 
Based on the dat~ in Table IV and on statistical analy-
sis, the following antibiotic susceptibility patterns can 
be formulated (Table VIII). Citrobacter freundii is charac-
terized by a sensitivity to ampicillin and carbenicillin, 
but is resistant to cephalothin and cefoxitin. C. diversus 
is characterized by being resistant to ampicillin and car-
benicillin, but sensitive to cephalothin and cefoxitin. C. 
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amalonaticus is characterized by a sensitivity to ampicil-
lin, carbenicillin, cephalothin, and cefoxitin. 
It is evident that all three biachemical types of C. 
fre~ndii show a similar antibiogram, but that in the case of 
H2s +, IND - and H2 s +, IND + C. fr~uridii strains, there is 
a small degree of variability in its reactions to several 
antibiotics, especially ampicillin. Studies done by Austen 
et al (1981) and Sawai et al (1982) help to explain this 
problem. They have been able to characterize the presence 
of the enzyme cephalosporinase in ~· freundii which breaks 
down cephalothin and cefoxitin. The "third generation" 
cephalosporins, represented in this study by cefotaxime, 
cefoperazone, and moxalactam, are protected from the cephal-
osporinase produced by the organism, and thus sensitivity 
to these drugs is seen. It was also found that some strains 
of C. freundii contained a plasmid that would allow the or-
ganism to produce a beta-lactamase (penicillinase) that 
would make the organism resistant to penicillin and ampi-
cillin (Austen et al, 1981; Sawai et al, 1982). This beta-
lactamase is also present in C. diversus, but to a signifi-
cantly larger extent than in C. freundii. The "new" peni-
cillins, such as mezlocillin and piperacillin, which have a 
protected beta-lactam ring, are effective against these 
beta-lactamase-producing Citrobacter. 
An interesting study into the evolutionary divergence 
of enteric bacilli, such as Citrobacter freundii, has re-
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sulted in a finding that may have a clinical significance 
(Blumenbe~g and Yanofsky, 1982). While studying the trypto-
phan operon regulatory region in enteric bacteria, these 
·authors found that certain strains nf C. freundii contained 
a plasmid (R factor) that was identical to one found in 
Escherichia coli. This factor carries the gene responsible 
for beta-lactamase (pen ru cillinase) production that makes 
both C. freundii and ~· coli resistant to ampicillin. Find -
ing that Citrobacter and Escherichia are similar in their 
gen~tic makeup, Blumenberg and Yanofsky concluded that it 
was possible that Citrobacter was derived from an ancestral 
form of Escherichia. 
With respect to the evolutionary relationship of 
Citrobacter to the family Enterobacteriaceae, most authori-
ties, including Edwards and Ewing (1972), have placed Citro-
bacter in the tribe Salmonellae. It seems to the author 
that, biochemically (Table IX), Citrobacter is intermediate 
in its characteristics between members of the tribes Escheri-
chiae and Salmonellae. Genetically, at least according to 
Blumenberg and Yanofsky (1982), Citrobacter is closer to the 
genus Escherichia than to the genera of the tribe Salmonel-
lae. 
SUMMARY 
One hundred and nine strains of Citr6b~~ter isolated 
from various clinical material at Dameron Hospital, Stockton, 
California between January 1983 and February 1984 were in-
vestigated. The organisms were identified as follows: c. 
freundii (81.65%), f. diversus (10.09%), and f. amalonati-
cus (8.26%). Biochemical types of C. freundii were also 
identified as follows: H
2
S +, IND - C. freundii (71.91%), 
H2 S +, IND +C. freundii (8.99%), and H2 S -, IND - C. 
freundii (19.10%) •. Each of the species was investigated 
with reference to distribution in clinical material, bio-
chemical activity, and antibiotic susceptibility. Compari-
sons between results obtained in this study and in other 
studies were made with respect to biochemical activities and 
antibiograms. It was found that C. freundii shows resist-
ance to cephalothin and cefoxitin, f. diversus is resistant 
to ampicillin and carbenicillin, and f. amalonaticus shows 
sensitivity to all antibiotics tested. This is in agreement 
with other investigators. 
Based on this study and available information in the 
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S +, IND + 
(n=8) 
c. freundii, 
H S - IND -2 ' ( n= 1 7) 





























(% positive reactions) 
API 
LDC one CIT 
0 30 25 
0 30 31 
0 100 100 
0 100 100 
0 35 18 
0 35 29 
0 100 100 











78 100 100 



























































_g_. freundii, . 
H2 S +, IND -(n=64) 
c. freundii, 
H2s +, IND + (n=8) 
c. freundii, 
H S - IND -2 Cn=i7) 
C. diversus 
( n= 11) 
C. amalonaticus 
(n=9) 
TABLE II (cont.) 






































































































































Carbenicillin (CB) 100 
Cephalothin (CR) 30 
Cefamandole (MA) 30 
Cefoxitin (FOX) 30 
Cefotaxime (CTX) 30 
c·e f ope raz one (CFP) 75 
Moxalactam (MOX) 30 
Tetracycline (TE) 30 
Gentamicin (GM) 10 
Kanamycin (K) 30 
Amikacin (AN) 30 
Tobramycin (TM) 10 
Zone D~ameter (to nearest mm) 
Resistant Intermed. Sensitive 
(mm or less) (mm or more) 
1 1 12-13 14 
1 7 18-22 23 
14 15-17 18 
14 15-17 18 
14 15-17 18 
14 15-22 23 
14 15-20 2 1 
14 15-22 23 
14 15-18 19 
12 13-14 15 
13 14-17 18 
14 15-16 1 7 
12 13-14 15 
Polymyxin B (PB) 300 units 8 9-11 12 
Chloramphenicol (C) 30 12 13-17 18 
Gantrisin (G) 300 12 13-16 17 
Trimethoprim-
Sulfamethoxazole 
(Bactrim-Septra; ·~.~ j 
SXT) 25 10 11-15 16 
Nitrofurantoin (FD)300 14 15-16 17 
Naladixic Acid (NA) 30 13 14-18 19 
Neomycin (N) 30 12 13-16 17 
Mezlocillin (MZ) 75 14 15-17 18 





H2 S +, IND -
(n=64) 
c. freundii 
H2 S +, IND + 
(n=8) 
c. freundii, 
H S - IND -2 ' ( n= 1 7) 
c. diversus 






















































































































































* - Significant differences seen between ~· diversus and other two species (chi square, 
~ =0.05) 




TABLE IV (cont.) 
Antibiograms of Citrobacter Species 
(% susceptible) 
Species PB c G SXT FD NA 
c. freundii, R 0 5 12 11 2 0 
H2 S +, IND -(n=64) s 100 95 88 89 98 100 
c. freundii, R 0 0 0 0 0 0 
Hz S +, IND + 
(n=8) s 100 100 100 100 100 100 
c. freundii, R 0 0 0 0 0 0 
H S -, IND -2 (n=17) s 100 100 100 100 100 100 
c. diver sus R 0 0 0 0 0 0 
(n ':'; ll). s 100 100 100 100 100 100 
c. amalonaticus R 0 0 0 0 0 0 


























Comparison of Biochemical Tests for C. freundii 



















H2 S +,IND -





















0 (7 5) 
Deaminase (TDA) 0 0 
Glucose 100 100 
Lactose 100 100 
Sucrose 75 ( 7 7) 100 
Inositol 9 0 
* - Stutly did not differentiate among 
C. freundii 



























7 7. 4 
o.o 
100.0 
-8 9. 1 
24.7_ 
4.2 




Comparison of Biochemical Tests for C. d~versus 
(% positive reactions) 
Ewing & Davis 
T~st C. div~rsus (1911,1972) 
Hydrogen 
Sulfide 0 0.0 
Urease 0 77. 9 
Indole 100 98.6 
Vogues-
Proskauer 0 0.0 
Simmons' 
* Citrate 100 99.6 
Gelatin 0 o.o 
Lysine 
Decarboxylase 0 0.0 
Ornithine 
Decarboxylase 100 100.0 
Arginine 
** Dihydrolase 9 1 (100) 82.6 
Phenylalanine 
Deaminase (TDA) 0 0.0 
Glucose 100 100.0 
Lactose 100 100.0 
Sucrose 91 16.8 
inositol 55 (64) 0.0 
* - Test is based on the API ZOE strip 
** - Figures in parentheses indicate percent-
ages of delayed reactions 
35 
TABLE VII 
Comparison of Biochemical Tests for C. amalonaticus 
(% positive reactions) 
Edwards & Ewing 























































H2 S +, IND -
C. freundii 
H2 S +, IND + 
C. freundii 





Identification of Citrobacter Species 

















































Citrobacter +I- + +I- # +/- -/(+) +/-
Salmonella + -I ( +) 
Arizona + (+) + 
*-Based on information found in Martin and Washington (1980). 
** - Some strains of Escherichia coli produce H
2
s. 








Comparison of Biochemical Reactions of 
Werkman and Gillen's Citrobacter Isolates and Those from Dameron Hospital 
Species CIT H2S IND VP GEL GLU ONPG MAN INO SOR RHA SAC AMY ARA · .. 
WERKMAN AND GILLEN'S ISOLATES 
c. freundii ( 2) + + - - - + + + + + + + - + 
c. album (2) + + - - + + + + + + - - + 
c. glycologenes (1) + - - - - + + + + + 
c. intermedium (4) + + - - - + + + - + + - - + 
w c. de co lorans (2) + + + - + + + + + + + + - + 1..0 
c. diver sum (2) + + + - - + + + + + + + - + 
c. anindolicum (2) + + - - - + + + + + + - + 
DAMERON. ISOLATES (Numbers represent % positive reactions of biochemical tests) 
c. freundii, 
H2 s +, IND - (64) 100 100 0 0 0 100 100 100 9 98 100 77 39 100 
c. freundii, 




S - ' IND - (17) 100 0 0 0 0 100 100 100 0 100 100 94 24 100 
c. diversus (11) 100 0 100 0 0 100 100 100 64 100 100 91 82 100 
c. amalonaticus (9) 100 0 100 0 0 100 100 100 0 100 100 89 78 100 
Aldredge, 
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